TARGETING RASD1 WITH FDA-APPROVED KRAS INHIBITORS FOR NEUROPROTECTION IN MS

$250,000FY2025Defense Health AgencyDOD

The Johns Hopkins University

Investigators

TARGETING RASD1 WITH FDA-APPROVED KRAS INHIBITORS FOR NEUROPROTECTION IN MS · GrantIndex